全体要約
関連する質問
31.4 billion USD (2026)
14.3% (2021 to 2026)
Laboratory Corporation of America Holdings, Eurofins Scientific SE, Charles River Laboratories International, Inc., Evotec SE, WuXi AppTec, Pharmaceutical Product Development LLC, Syngene International Limited, Curia Global Inc., Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies), Pharmaron Beijing Co., Ltd., Piramal Enterprises Limited, Thermo Fisher Scientific Inc., Jubilant Pharmova Limited, GenScript Biotech Corporation, Selvita S.A., Shanghai Medicilon Inc., Viva Biotech (Shanghai) Ltd., TCG Lifesciences Pvt Ltd., Shanghai ChemPartner Co., Ltd., Domainex Ltd., NUVISAN Pharma Holding GmbH, Frontage Holdings Corporation, Dalton Pharma Services, Aragen Life Sciences Pvt. Ltd., Promega Corporation
R&D支出の増加、希少疾病とオーファンドラッグに対する研究の取り組み、分析試験サービスのアウトソーシングニーズの高まり
概要
目次
Description
Table of Contents